The regulatory effect of CHREBP on cell cycle-related genes has been reported in benign β-cell growth and malignancy activity of prostate carcinoma, but correlational study involving CHREBP binding directly to the promoter regions of these genes is still lacking [17, 25]. This evidence concerns the gene MLXIPL and prostate carcinoma.